The largest database of trusted experimental protocols

Eba 20 centrifuge

Manufactured by Hettich
Sourced in Germany

The EBA 20 is a compact and robust centrifuge designed for general laboratory applications. It features a maximum speed of 6,000 rpm and a maximum RCF of 3,220 x g. The EBA 20 can accommodate a variety of sample tubes and has a compact footprint, making it suitable for use in limited space environments.

Automatically generated - may contain errors

11 protocols using eba 20 centrifuge

1

Pharmacokinetics of Capmatinib in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
The rats were randomized, weighed, and tail marked into two groups, namely a capmatinib-administered group and a placebo group (n = 6). The capmatinib was freshly dissolved in a 0.5% carboxymethylcellulose (CMC) solution prepared in distilled water while the placebo solution consisted of 0.5% CMC alone. The fasting rats (12 h, water ad libitum) were administered either capmatinib at 10 mg/kg dose or an equivalent amount of 0.5% CMC solution by oral gavage using a stainless-steel oral gavage needle (Harvard Apparatus, Holliston, USA).
A volume of 200 µL of the blood samples was obtained from the retro-orbital plexus using clean capillary tubes and collected into Minicollect EDTA tubes. Blood sampling was performed under light isoflurane anesthesia (Hikma Pharmaceuticals, Amman, Jordan) (5% induction and 2.5% maintenance) carried by oxygen (dual-flow oxygen concentrator, China) using a low-flow anesthesia system (SomnoSuite, Kent Scientific, Torrington, CT, USA). An initial blood sample, a zero-time sample, was collected from each animal. The blood samples were then collected at specific time intervals at 0.25, 0.50, 1, 2, 4, 8, and 24 h post-drug administration. The collected blood tubes were centrifuged for 10 min at 6000 rpm using a Hettich EBA 20 centrifuge, Tuttlingen, Germany. The clear plasma samples were then collected and stored at −80 °C until HPLC analysis.
+ Open protocol
+ Expand
2

Graphene Nanosheets Synthesis via Exfoliation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Graphene nanosheets (3-4 layers, ~500 um surface diameter) were prepared via water-assisted liquid phase exfoliation of graphite. Briefly, 50 mg microcrystalline graphite powder (325 mesh, 99.995% pure, purchased from Alfa Aesar, UK) was immersed in N-methyl-2-pyrrolidone (NMP) mixture with a 0.2 mass fraction of water. The initial concentration of graphite was fixed at 5 mg mL -1 for exfoliation. NMP, 99% extra pure was purchased from Acros Organics (USA). The materials were batch sonicated for 6 hours in a bath sonicator (Elma sonic P60H, Switzerland) at a fixed nominal power and frequency of 100 W and 37 kHz respectively. Sample dispersions were hanged on for overnight in between sonication and centrifugation and were centrifuged at 3000 rpm for 30 minutes using a Hettich EBA20 centrifuge (Germany). The upper 75% of the colloidal supernatant were collected and dried in an oven to yield the graphene nanosheets.
+ Open protocol
+ Expand
3

HPLC-MS/MS Profiling of Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments were performed using a 1200 high-performance liquid chromatograph combined with a 6410 triple quadrupole mass spectrometer from Agilent Technologies (Santa Clara, CA, USA). The system was equipped with an electrospray ionization (ESI) operating in positive mode. An InfinityLab Poroshell 120 EC-C18 column (4.6 × 100 mm × 2.7 µm) also from Agilent was used for chromatographic separation. Data were collected and processed using the MassHunter Quantitative Analysis (QqQ) software, using the multiple reaction monitoring (MRM) mode. SigmaPlot 13.1 (Systat Software, San Jose, CA, USA) and MetaboAnalyst 5.0 software were used for the statistical analysis.
An EBA 20 centrifuge (Hettich, Tuttlingen, Germany), an XcelVap air-drying system (Horizon Technology, Salem, MA, USA) and an LLG-uniTEXER vortex (Heathrow Scientific, IL, USA) were used during sample treatment. Tissue samples were ground with an IKA A11 basic mixer (Wilmington, USA). Nylon syringe filters of 0.45 μm × 25 mm and 0.2 μm × 13 mm from Agilent were used to filter the sample extracts.
+ Open protocol
+ Expand
4

RBC Isolation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Haemolytic experiments and morphological observations were performed on red blood cells (RBCs), isolated from the whole blood, containing heparin or sodium citrate as anticoagulation agents. Briefly, the whole blood was centrifuged at 1000× g rpm (at Hettich EBA-20 centrifuge, Tuttlingen, Germany) for 5 min and the upper layer of plasma was carefully removed. The remaining RBC pellet was washed three times with PBS, re-dispersed with PBS to initial volume and was further used for the experiment.
+ Open protocol
+ Expand
5

Vortexing and Centrifugation Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
All shaking steps were performed using a Vortex Genie from Scientific Industries (Bohemia, NY, USA). For centrifugation of 15 mL tubes, an EBA 20 centrifuge, Hettich (Tuttlingen, Germany) was used. All microcentrifuge tubes were centrifuged with a 5415 D centrifuge from Eppendorf (Hamburg, Germany).
+ Open protocol
+ Expand
6

Preparation and Characterization of NADES

Check if the same lab product or an alternative is used in the 5 most similar protocols
The preparation of Natural Deep Eutectic Solvents (NADES) involved mixing choline chloride and the second constituent in different molar ratios. The obtained mixtures were transferred to sealed test tubes and placed in a water bath with a temperature of 90 °C until the formation of a uniform solution. Again, an excess amount of theobromine was added to the test tubes containing both pure NADES, as well as their mixtures with water, in which the NADES was treated as a cosolvent and added in varying molar ratios. The samples were then incubated for 24 h at 25 °C, similarly as for organic solvents. The increased viscosity and density of NADES required the samples to be centrifuged at 1000 rev/min for 5 min with the use of EBA 20 centrifuge from Hettich for the undissolved precipitate to remain on the bottom of the test tube. Further procedure included filtration and spectrophotometric measurements, as it was the case for organic solvents.
+ Open protocol
+ Expand
7

Assessing Whey Protein Isolate Solubility

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protein solubility of WPI gels was determined in five different solvent systems: in phosphate buffer 0.025 mol.L-1, pH 7 (PB), PB and 1% sodium dodecyl sulphate (SDS), PB and Urea 8 mol.L-1 (U), PB and 0.2% 2-mercaptoethanol (2-Me) and the conjugation of all the previous. Cylindrical gel samples of 5 � 5 mm (�0.5 g) were individually weighed, placed in glass screwcap tubes and 5 mL of each one of the solutions added. The experiments took place under agitation on an orbital shaker (KL-2 Edmund Buhler. Germany) at 60 rpm at room temperature during a period of 5 days. At days 1, 3 and 5, the samples were centrifuged at 3421 ⊆g for 5 min on an EBA 20 centrifuge (Andreas Hettich GmbH & Co.KG. Tuttlingen, Germany). After centrifugation, supernatant fractions were recovered and the soluble protein determined by absorbance at 280 nm on a UV-VIS spectrophotometer (V-560. Jasco Inc.. Tokyo. Japan) using and absorbance coefficient of 0.9565 g-1 cm-1.
+ Open protocol
+ Expand
8

Assessing Whey Protein Isolate Solubility

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protein solubility of WPI gels was determined in five different solvent systems: in phosphate buffer 0.025 mol.L-1, pH 7 (PB), PB and 1% sodium dodecyl sulphate (SDS), PB and Urea 8 mol.L-1 (U), PB and 0.2% 2-mercaptoethanol (2-Me) and the conjugation of all the previous. Cylindrical gel samples of 5 � 5 mm (�0.5 g) were individually weighed, placed in glass screwcap tubes and 5 mL of each one of the solutions added. The experiments took place under agitation on an orbital shaker (KL-2 Edmund Buhler. Germany) at 60 rpm at room temperature during a period of 5 days. At days 1, 3 and 5, the samples were centrifuged at 3421 ⊆g for 5 min on an EBA 20 centrifuge (Andreas Hettich GmbH & Co.KG. Tuttlingen, Germany). After centrifugation, supernatant fractions were recovered and the soluble protein determined by absorbance at 280 nm on a UV-VIS spectrophotometer (V-560. Jasco Inc.. Tokyo. Japan) using and absorbance coefficient of 0.9565 g-1 cm-1.
+ Open protocol
+ Expand
9

Saponification and Extraction of Polysorbate 80

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analogous to Ilko et al. [21 (link)] a modified saponification and extraction process was employed. In 10.0 mL of a 10% methanolic (v/v) 1 M KOH solution, 15 mg of the PS 80 (n = 3) was incubated at 40 °C for 6 h. Subsequently, 250 µL of this solution was mixed with 50 µL formic acid in a glass centrifuge tube (VWR, Darmstadt, Germany) to obtain an acidic pH value. After addition of 500 µL tert.-butyl methyl ether and vortexing, an incubation period of 5 min was applied before centrifuging the tubes at 2700× g for 5 min (EBA 20 centrifuge, Hettich, Tuttlingen, Germany). Finally, the collected organic phase was evaporated under a stream of nitrogen and the residue was dissolved in 1000 µL of the solvent mixture. A blank sample without PS 80 was prepared according to the procedure described above.
A 0.1 mg/mL test solution was prepared by dissolving 10.0 mg of magnesium stearate in 100.0 mL of the solvent mixture. A reference solution of magnesium acetate × 4 H2O (0.05 mg/mL) in water was also analyzed.
+ Open protocol
+ Expand
10

Validating Xpert HIV-1 VL Assay for Clinical Specimens

Check if the same lab product or an alternative is used in the 5 most similar protocols
To verify the Xpert HIV-1 VL assay (referred to as Xpert VL) as ‘fit-for-purpose’ prior to clinical specimen testing, a standardised, 42 member, frozen, subtype-C plasma panel (termed the South African Viral Quality Assessment–SAVQA) [11 (link)], was included in the evaluation. The SAVQA panel consisted of 22 HIV-negative specimens and 20 HIV-positive specimens ranging from 750 to 21000cp/ml (2-4log cp/ml) and is designed to measure accuracy and precision.
For assay validation, three clinical specimen types were tested on the Xpert VL assay (Fig 1); whole blood, plasma and DBS. DBS were prepared immediately upon specimen receipt, by pipetting 70μl of whole blood per spot onto a Munktell 903 filter card (LabMate Pty, Ltd, Cape Town, South Africa) (four spots per card), air dried for 2 hours and then stored at -20°C in a zip-lock plastic bag with dessicant for later testing. Whole blood did not require any pre-processing before testing on the Xpert VL assay. To obtain plasma, residual whole blood was centrifuged at 3000rpm for 15 minutes using a Hettich EBA-20 centrifuge (Hettich AG, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!